GENITOURINARY SYNDROME OF MENOPAUSE IN PERI- AND POSTMENOPAUSAL PATIENTS: DIAGNOSIS AND THERAPY (short clinical guidelines)
- Authors: Yureneva S.V.1, Ermakova E.I.1, Glazunova A.V.1
-
Affiliations:
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Issue: No 5 (2016)
- Pages: 138-144
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247714
- ID: 247714
Cite item
Open Access
Access granted
Abstract
Objective. To present basic clinical research data based on the current evidence about peri- and postmenopausal anatomic and physiological changes in the urogenital tract and on the principles of management of patients with genitourinary syndrome of menopause. Material and methods. Russian and foreign sources dealing with the prevalence, current diagnosis, and treatments of vaginal atrophy were reviewed. Results. The present clinical guidelines give current terminology and data on the etiopathogenesis, clinical presentation, diagnosis, and treatments of vulvovaginal atrophy or urinary discomfort in peri- and postmenopausal women. Conclusion. Genitourinary syndrome of menopause is a common disorder in peri- and postmenopausal women. The knowledge of the current aspects of its diagnosis, treatment, and prevention will be able to render timely aid to patents and to improve their quality of life.
Full Text
About the authors
Svetlana V. Yureneva
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: syureneva@gmail.com
MD Moscow 117997, Ac. Oparina str. 4, Russia
Elena I. Ermakova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: ermakova.health@mail.ru
PhD Moscow 117997, Ac. Oparina str. 4, Russia
Angelina V. Glazunova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: lianochkal85@yandex.ru
postgraduate of gynecological endocrinology department Moscow 117997, Ac. Oparina str. 4, Russia
References
- Sinha A., Ewies A.A. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric. 2013; 16(3): 305-12.
- Griebling T.L., Liao Z., Smith P.G. Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women. Menopause. 2012; 19(6): 630-5.
- Frank S.M., Ziegler C., Kokot-Kierepa M., Maamari R., Nappi R.E. Vaginal health: insights, views & attitudes (VIVA) survey - Canadian cohort. Menopause Int. 2013; 19: 20-7.
- Pastore L.M., Carter R.A., Hulka B.S., Wells E. Self-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative. Maturitas. 2004; 49(4): 292-303.
- Rosano G.M.C., Vitale C., Silvestri A., Fini M. Metabolic and vascular effect of progestins in post-menopausal women. Implications for cardioprotection. Maturitas. 2003; 46(Suppl.): S17-29.
- Hextall E. Oestrogens and lower urinary tract function. Maturitas. 2000; 36(2): 83-92.
- Балан В.Е., Гаджиева З.К. Нарушения мочеиспускания в климактерии и принципы их лечения. Русский медицинский журнал. 2000; 8(7): 284-7.
- Манухин И.Б., Тумилович Л.Г., Геворкян М.А. Клинические лекции по гинекологической эндокринологии. М.; 2003.
- Pickar J.H. Emerging therapies for postmenopausal vaginal atrophy. Maturitas. 2013; 75(1): 3-6.
- Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause. 2013; 20(9): 888-902.
- Palacios S. Managing urogenital atrophy. Maturitas. 2009; 63(4): 315-8.
- Sturdee D.W., Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010; 13(6): 509-22.
- Basaran M., Kosif R., Bayar U., Civelek B. Characteristics of external genitalia in pre-and postmenopausal women. Climacteric. 2008; 11(5): 416-21.
- Адамян Л.В., Курило Л.Ф., Глыбина Т.М., Окулов А.Б. Аномалии развития органов женской репродуктивной системы: новый взгляд на морфогенез. Проблемы репродукции. 2009; 4: 10-9.
- Monz B., Pons M.E., Hampel C., Hunskaar S., Quail D., Samsioe G. et al. Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries. Maturitas. 2005; 52(Suppl. 2): S24-9.
- Есефидзе Ж.Т. Клиника, диагностика и лечение атрофического вагинита в постменопаузе. Русский медицинский журнал. 2001; 9(9): 370-4.
- Castelo-Branco C., Cancelo M.J., Villero J., Nohales F., Julia M.D. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas. 2005; 52(Suppl. 1): S46-52.
- Jaisamrarn U., Triratanachat S., Chaikittisilpa S., Grob P., Prasauskas V., Taechakraichana N. Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy. Climacteric. 2013; 16: 1-9.
- Lingman K. Genuine stress incontinence. Curr. Obstet. Gynecol. 2001; 2: 353-8.
- Cardozo L., Staskin D., eds. Textbook of female urology and urogynaecology. Martin Dunitz; 2005: 183-227.
- Кулаков В.И., Аполихина И.А. Недержание мочи у женщин: новые возможности в диагностике и лечении. Гинекология. 2004; 4(3): 103-5.
- Kirchin V., Page T, Keegan P.E., Atiemo K., Cody J.D., McClinton S. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst. Rev. 2012; 2: CD003881.
- Shah S.M., Gaunay G.S. Treatment options for intrinsic sphincter deficiency. Nat. Rev. Urol. 2012; 9(11): 638-51.
- Сивков А.В., Ромих В.В. Фармакотерапия гиперактивного мочевого пузыря. Consilium medicum. 2002; 7: 348-54.
- Moore K.H. Conservative management for urinary incontinence. Baillieres Best. Pract. Res. Clin. Obstet. Gynaecol. 2000; 14(2): 251-89.
Supplementary files
